Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.

[1]  Carsten Lührs,et al.  EuroSCORE predicts intensive care unit stay and costs of open heart surgery. , 2004, The Annals of thoracic surgery.

[2]  C. Eby,et al.  Transfusion medicine service policies for recombinant factor VIIa administration , 2004, Transfusion.

[3]  D. McIlroy,et al.  Recombinant factor VIIa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotinin. , 2004, Anesthesia and analgesia.

[4]  V. Fuster,et al.  Tissue Factor Coagulation Pathway: A New Therapeutic Target in Atherothrombosis , 2004, Journal of cardiovascular pharmacology.

[5]  Piotr Jarosik,et al.  The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass* , 2004, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[6]  M. Herbertson.  Recombinant activated factor VII in cardiac surgery , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[7]  J. Egan,et al.  Recombinant activated factor VII in paediatric cardiac surgery , 2004, Intensive Care Medicine.

[8]  S. Merrick,et al.  Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair. , 2003, Annals of Thoracic Surgery.

[9]  Kenichi A. Tanaka,et al.  Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). , 2003, Anesthesiology.

[10]  C. Mazer,et al.  Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[11]  K. Kurth,et al.  Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial , 2003, The Lancet.

[12]  J. Berkenbosch,et al.  Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant , 2003, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[13]  G. Patterson,et al.  Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. , 2002, The Journal of thoracic and cardiovascular surgery.

[14]  W. Konertz,et al.  Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery. , 2002, Journal of cardiothoracic and vascular anesthesia.

[15]  M. Spannagl,et al.  Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery. , 2002, Anesthesia and analgesia.

[16]  E. Erhardtsen,et al.  Potential role for rFVIIa in transfusion medicine , 2002, Transfusion.

[17]  J. Meer,et al.  An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII , 2001 .

[18]  R. Santucci,et al.  Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. , 2000, The American journal of pathology.

[19]  M. Al Douri,et al.  Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[20]  Ravi,et al.  SUCCESSFUL USE OF RECOMBINANT FVIIa (NOVOSEVEN®) IN THE MANAGEMENT OF INTRACTABLE POST‐SURGICAL INTRA‐ABDOMINAL HAEMORRHAGE , 1999, British journal of haematology.

[21]  Gili Kenet,et al.  Treatment of traumatic bleeding with recombinant factor VIIa , 1999, The Lancet.

[22]  D. Bevan.  Cardiac bypass haemostasis: putting blood through the mill , 1999, British journal of haematology.

[23]  Dougald M Monroe,et al.  Safety profile of recombinant factor VIIa. , 2004, Seminars in hematology.

[24]  R. Gill,et al.  New alternatives for control of severe cardiac surgical bleeding , 2004 .